On May 8, 2019 OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, reported that it will release its financial and operating results for the first quarter ended March 31, 2019, on Tuesday, May 14, 2019, after the close of the U.S. financial markets (Press release, BioTime, MAY 8, 2019, View Source;p=RssLanding&cat=news&id=2397802 [SID1234535992]). The Company will host a conference call on Tuesday, May 14, 2019 at 4:30 pm ET / 1:30 pm PT to discuss the results along with recent corporate developments.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The dial-in number in the U.S./Canada is 877-407-9716; for international participants, the number is 201-493-6779. For all callers, please refer to Conference ID 13689785. To access the live webcast, go to the investor relations section on the Company’s website, View Source